|
Don't miss out on this opportunity to learn from expert faculty, and network and engage with over 700 attendees and over 100 Fellows and Residents.
Register today!
| |
|
We all have opinions — and physicians aren't the only ones sharing what they think about the hot-button topics of the day, including vaccines, the pandemic, politics, and global affairs, on social media.
Unfortunately, these posts don't always land well. In fact, according to Medscape Medical News' Physicians Behavior Report 2023, 21% of doctors reported seeing other physicians behaving inappropriately on social media, with one of the worst offenders being the contradiction of the use of vaccinations to prevent the spread of COVID and the implication vaccines lead to mortality and disability.
If you're a regular social media enthusiast, it bears repeating: Your posts can be a major liability, especially if you'll be applying for another job, planning to relocate, or even opening your own practice someday.
Read More
| |
Join the AMA or Renew your Membership Today!
As of now, ASIPP has two positions available in the House of Delegates and all of the other memberships where they are available, even for the other societies within AMA. The American Medical Association (AMA) requires all societies to requalify for membership in the AMA House of Delegates (HOD) every five years. To keep and hopefully increase ASIPP's membership in these committees, we have to keep at a minimum 20% AMA membership, otherwise, ASIPP will lose the AMA membership with all the available advantages.
We encourage you to join or renew your membership in the AMA. Joining the AMA will further strengthen our specialty’s representation at the national level through the AMA House of Delegates, the AMA’s policymaking body, and strengthen our ability to meet the challenges in health care today with thoughtful, well-organized responses.
As a member of the AMA, you become part of the organization that unites physicians nationwide to tackle the major issues we all face: 47 million uninsured Americans, looming Medicare payment cuts, and the need for medical liability reform. Membership also gives you access to a broad range of practice management resources and award-winning publications such as the Journal of the American Medical Association, AMNews, AMA Morning Rounds, and the Archives journals.
Please take this opportunity to support the critical activities of ASIPP by joining the AMA today. To join or renew the AMA, we encourage you to visit www.ama-assn.org or call (800) 262-3211.
| |
|
Key Points
Question Is there an association between concomitant use of selective serotonin reuptake inhibitors (SSRIs) and oral anticoagulants (OACs) and the risk of major bleeding among patients with atrial fibrillation compared with OAC use alone?
Findings In this nested case-control study comprising 42 190 cases with major bleeding matched to 1 156 641 controls, concomitant SSRI and OAC use was associated with a 33% increased risk of major bleeding compared with OAC use alone; this risk was highest in the first few months of concomitant use and was substantially lower after 6 months.
Meaning This study suggests that concomitant use of SSRIs and OACs may be a risk factor for bleeding and should be closely monitored, particularly within the initial months of treatment.
Read More
| |
|
Virtual
April 27, May 25, June 29, & July 27
Click here for the complete list of upcoming exams.
ABIPP Part I; ABIPP Path - Combined DCCPM/CSM virtual exam;
ABIPP Competency Exam in IPM; ABIPP Competency Exam in Regenerative Medicine;
CSM Competency Exam; DCCPM Competency Exam
In Person
October 18, 2024
ABIPP Part II - Practical Examination
Lab Venue: MERI, 44 S. Cleveland Street, Memphis, TN 38104
| |
|
Summary
Researchers unveiled a groundbreaking mechanism where the lungs directly inform the brain of infections, altering traditional views on sickness response. This study, conducted in mice, demonstrates that neurological pathways, rather than just immune responses, are responsible for symptoms of illness.
The findings suggest that treating respiratory infections and chronic lung conditions might require approaches that target both the nervous system and the pathogen.
Additionally, the study observed a gender difference in sickness behavior, potentially offering a scientific basis for the so-called “man flu,” with males showing greater dependence on neuronal communications during illness.
Read More
| |
|
Princess Kate's cancer diagnosis at age 42 shines a light on a dreaded disease that seems to be striking people at younger ages, though it has become more survivable.
Americans have about a 40% chance of developing cancer at some point in their lives. Just under 20% who develop it die from cancer, which is the second-leading cause of death in the U.S.
It is typically considered a disease of aging, with 88% of diagnoses coming in people age 50 and above, according to the American Cancer Society.
Read More
| |
|
Excellent opportunities for Residents & Fellows
at ASIPP's 2024 Annual Meeting:
- Abstract Session (April 4, 3:30–5:30pm) and Podium Presentation for Best Abstracts during General Session (April 5, 3:30–4:15pm)
- Half-Day Session dedicated to Young Physicians in Interventional Pain Management
| |
|
Primary Care Flex will pay ACOs a monthly fee to be given to primary care practices
Medicare is trying again with another accountable care organization (ACO) payment model aimed at primary care doctors, but reactions to the new model are mixed so far.
The voluntary model, known as ACO Primary Care Flex, would pay organizations that participate in Medicare's Shared Savings Program a monthly fee that would be distributed to the ACO's primary care practices. The CMS announced the new model last week; it will begin operating on Jan. 1, 2025.
"Premier applauds CMS for releasing its ACO Primary Care Flex model, which will test primary care capitation in the Medicare Shared Savings Program (MSSP)," Seth Edwards, vice president of population health and value-based care at Premier, a healthcare group purchasing firm, said in a statement. "However, Premier is disappointed in the limited scope of what could be a promising model to help ACOs shift off the fee-for-service chassis."
Read More
| |
|
Tennessee nurse practitioner promoted his practice with the motto "work hard, play harder"
A Tennessee nurse practitioner who called himself the "Rock Doc" has been sentenced to 20 years in prison for illegally prescribing thousands of doses of opioids, including oxycodone and fentanyl in return for money and sex, federal prosecutors said Tuesday.
Jeffrey W. Young Jr., was sentenced Monday in federal court, about a year after he was convicted of unlawfully distributing and dispensing controlled substances out of a clinic in Jackson, Tennessee. There is no parole in the federal court system.
Young, 49, was among 60 people indicted in April 2019 for their roles in illegally prescribing and distributing pills containing opioids and other drugs. Authorities said the defendants included 53 medical professionals tied to some 350,000 prescriptions and 32 million pills.
Read More
| |
ASIPP State Society Meetings | |
|
Early life pain exposure alters brain development in preterm infants, particularly female infants, according to a new study.
The observational cohort study collected and analyzed data from 150 infants born at less than 32 weeks' gestation. Its findings demonstrated that early life exposure to pain affects brain development in very preterm infants. Additionally, the investigators found sex-specific associations between pain exposure and brain development, with female infants experiencing a greater impact on brain connectivity.
"Painful exposures are part of lifesaving care for these babies in the neonatal intensive care unit [NICU]. Our work emphasizes that you need to discover new ways to treat pain in preterm babies that promote brain development," study author Thiviya Selvanathan, MD, PhD, a pediatric neurologist at BC Children's Hospital and assistant professor of pediatrics at the University of British Columbia in Vancouver, told Medscape Medical News.
Read More
| |
|
Agency Issues Warning Letters to Six Companies for Marketing Unapproved, Misbranded Products
The U.S. Food and Drug Administration is warning consumers not to use certain over-the-counter analgesic (pain relief) products that are marketed for topical use to relieve pain before, during or after certain cosmetic procedures, such as microdermabrasion, laser hair removal, tattooing and piercing. The agency issued warning letters to six companies for marketing these products in violation of federal law.
Some of these products are labeled to contain ingredients, such as lidocaine, at concentrations that are higher than what is permitted for over-the-counter, topical pain relief products. When these products that contain high concentrations of lidocaine intended to be used before or during certain cosmetic procedures are applied in ways that could lead to increased absorption of the drug product through the skin, it may lead to serious injury such as irregular heartbeat, seizures and breathing difficulties. These products may also interact with medications or dietary supplements a consumer is taking.
“These products pose unacceptable risks to consumers and should not be on the market,” said Jill Furman, J.D., director of the Office of Compliance in the FDA’s Center for Drug Evaluation and Research. “We are committed to using all available tools to stop the sale of these illegal high-risk products.”
Read More
| |
- ASIPP Members Only Site Information - | |
-
To log in for the first time you will need to click “forgot password” at the bottom of the login window.
- Check your email and then log in as directed.
-
If you have problems logging into your account, click here.
| |
Pain Medicine Case Reports (PMCR) and Editor-in-Chief Alaa Abd-Elsayed, MD, PhD would like to invite you to submit case reports and case series to the PMCR journal. Your article will be published free of charge.
Open access journals are freely available online for immediate worldwide open access to the full text of published articles. There is no subscription fee for open access journals. Open access journals are no different from traditional subscription-based journals: they undergo the same peer-review and quality control as any other scholarly journal.
Interested in becoming a member of the PMCR Editorial Board?
Editorial board members are asked to review 2-6 manuscripts per year. Please submit your most up-to-date CV to sgold@asipp.org for consideration.
For more information or to submit your articles, click here.
| |
|
Om Dave, BS, Maryam Jowza, MD, and Daniel Nance, BS
Abstract
BACKGROUND: Centrally mediated abdominal pain syndrome (CAPS) is a condition that has traditionally been treated with first-line agents, such as tricyclic anti-depressants and serotonin and norepinephrine reuptake inhibitors. However, in the setting of pain refractory to these primary agents, there is little evidence in support of alternative regimens, especially opioid analgesics.
CASE REPORT: This case examines the utility of weekly 10 mcg transdermal buprenorphine patches as an additional treatment modality for CAPS, specifically in the setting of a 27-year-old woman with intractable abdominal pain following a cholecystectomy. In < 1 week, the patient had significant improvement in pain control without any of buprenorphine’s potential side effects.
CONCLUSION: Given the debilitating pain CAPS causes alongside the widespread economic burden it puts on both patients and hospital systems, transdermal buprenorphine can be a transformative approach to mitigating the consequences of this syndrome.
KEY WORDS: Abdominal pain, buprenorphine, opioids, chronic pain, interventional pain
Read More
| |
|
Kenny Do, BS, Eric Kawana, BS, Vladislav Zhitny, MD, Michael C. Wajda, MD, Shengping Zou, MD, Jenifer Do, ., Navdeep Singh, MD, Valeryia Pratasava, MD, Harsha Dannapaneni, MD, Rae Stewart, MD, and Ryan T. Gualtier, MD
Abstract
BACKGROUND: Glossopharyngeal neuralgia (GPN) is a rare cause of facial pain that has an incidence of less than one per 100,000 people. The excruciating stabbing pain experienced by patients with GPN can be debilitating, leading to difficulties in activities of daily living, such as eating and speaking. As a result, there has been a recent increase in research on the effectiveness of radiofrequency ablation (RFA) for treating GPN.
OBJECTIVE: The objective of our study was to evaluate the effectiveness of (RFA for treating GPN while examining its impact on patients’ quality of life and assesses for any associated side effects.
STUDY DESIGN: The Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) model was employed to identify articles from 2 comprehensive medical databases. The patient outcomes and numbers from each article were aggregated and calculated in order to determine the percent efficacy of RFA for treating pain associated with GPN.
METHODS: In this systematic review, the PRISMA review model was utilized to search through the PubMed and EMBASE databases. A comprehensive literature review was conducted. Of the initial 1,580 articles identified, 18 articles were included for analysis. Studies included in this systematic review encompassed idiopathic cases and secondary causes, such as an elongated styloid process, oropharyngeal cancers, and postsurgical/traumatic pain.
RESULTS: Of the 288 patients treated with RFA, 231 experienced relief or complete resolution of pain, yielding an efficacy rate of 80.2%. Most of the patients experienced immediate pain relief after RFA; however, some patients reported numbness, dysphagia, and changes in taste. Our study examines the potential use of RFA as a minimally invasive and effective treatment for GPN.
LIMITATIONS: Limitations of our study include the absence of comparisons between different types, modes, and settings of RFA procedures. The use of only 2 medical databases is another limitation. Finally, our systematic review does not include any randomized controlled trials.
CONCLUSION: RFA is efficacious in treating GPN with over 80% of patients experiencing postprocedure pain relief. However, further research in the form of clinical and controlled trials is needed to contribute to a better understanding of RFA’s long-term outcomes for patients with GPN.
KEY WORDS: Glossopharyngeal neuralgia, facial pain, radiofrequency ablation, facial pain, chronic pain management, pain measurement
Read More
| |
|
Yi Mao, MMed, Junchao Zhang, MMed, Yunzhong Zhan, MMed, and Zhou Ye, MMed
Abstract
BACKGROUND: Unilateral percutaneous endoscopic debridement and drainage (UPEDD) and bilateral PEDD (BPEDD) are commonly implemented, and have consistently yielded favorable clinical outcomes. Nevertheless, there is a scarcity of literature contrasting the advantages and disadvantages between these 2 procedures.
OBJECTIVE: The goal of this research was to conduct a meta-analysis to compare the clinical effects of UPEDD and BPEDD.
STUDY DESIGN: A systematic review and meta-analysis.
METHODS: A systematic review of studies reporting outcomes following UPEDD and/or BPEDD procedures was performed. The extracted data were used for meta-analysis. Pooled event rates for positive bacteria culture, pain control satisfaction, reoperation, and complications were estimated. The pooled operation time and blood loss were also calculated.
RESULTS: Among 764 retrieved articles, 28 studies with 661 patients met the inclusion criteria and were used for our meta-analysis. A total of 21 studies (462 patients) investigated UPEDD outcomes and 7 studies (199 patients) investigated BPEDD outcomes. For the UPEDD group, the pooled event rates for positive bacteria culture, pain control satisfaction, reoperation, and complications were 72%, 91%, 9% and 4%, respectively; the pooled operation time and blood loss were 89.90 minutes and 59.77 mL. For the BPEDD group, these were 79%, 92%, 4%, 8%, 93.23 minutes and 64.93 mL, respectively.
LIMITATIONS: First, all included studies were retrospective series, limiting our study design to a single-arm meta-analysis. Second, there was a limited amount of studies that were determined to be fitting, particularly on BPEDD; the sample size was also small. Third, the clinical effects of UPEDD and BPEDD needed to be compared in greater detail, such as the time it took for inflammatory markers to return to normal, the incidence of local kyphosis, and whether the duration of antibiotic use could be shortened after adequate debridement with BPEDD. Lastly, further studies are necessary to compare the clinical outcome of PEDD and percutaneous endoscopic interbody debridement and fusion.
CONCLUSIONS: Both UPEDD and BPEDD can provide a relatively reliable causative-pathogen identification and satisfactory clinical outcome. The 2 techniques are not significantly different in terms of positive bacteria culture rate, pain control satisfaction rate, complication rate, and reoperation rate.
KEY WORDS: Percutaneous endoscopic debridement and drainage, unilateral, bilateral, spinal infection
Read More
| |
|
ASIPP is now in collaboration with Curi Medical Liability Program
| |
|
Since this malpractice insurance program officially launched in November 2018, ASIPP has signed up hundreds of providers with an average savings of 30%. This is professional liability insurance tailored to our specialty and will stand up for us and defend our practices.
Curi is a full-service advisory firm that serves physicians and their practices. Their valued advice is grounded in your priorities and elevated in your outcomes. They are driven by a deep understanding of your specific circumstances in medicine, business, and life. To read a few important points to keep in mind about the program, including discounts, administrative defense, cyber coverage, aggressive claims handling, and complimentary risk management CME activities, visit our website.
| | |
|
Group Purchasing Organization Offer Better Pricing and Creates Added Value
ASIPP has formed a partnership with Henry Schein and PedsPal, a national GPO that has a successful history of negotiating better prices on medical supplies and creating value-added services for independent physicians. Working with MedAssets, PedsPal provides excellent pricing on products like contrast media that alleviate some of the financial pressures you experience today.
Learn More
| |  |
|
ASIPP, Fedora Billing,
and Revenue Cycle Management Partnership
ASIPP is now offering our members the benefit of a unique revenue cycle management/ billing service.
We have received a tremendous amount of interest in the ASIPP® billing and coding program.
Click here to learn more about the negotiated rate for practices and more!
| |
|
Like and follow ASIPP® on Facebook, X, and LinkedIn for the most
up-to-date news related to you, your practice, and your patients!
| | | | |
